Crossmark

Mehr Evidenz und faire Preise für neue Arzneimittel – dringender als je zuvor

Crossref DOI link: https://doi.org/10.1007/978-3-662-72460-6_19

Published Online: 2025-12-08

Published Print: 2025

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Jablonka, Sabine
Funding

Funding for this research was provided by:

Wissenschaftliches Institut der AOK
License Information

Text and Data Mining valid from 2025-01-01

Version of Record valid from 2025-12-08
More Information

Chapter History

First Online: 8 December 2025